TP53 Alterations Are Associated With Poor Survival in Patients With Primary Mediastinal Nonseminoma Germ Cell Tumors.
Jack V W BaconPatrizia GiannatempoGiovanna CataldoLadan FazliNeetu SaxenaGuliz OzgunMaryam SoleimaniKim ChiCraig NicholsAndrea NecchiAlexander W WyattChristian K KollmannsbergerLucia NappiPublished in: The oncologist (2022)
TP53 alterations are common in PMNSGCT and are associated with reduced overall survival, potentially underlying the poor sensitivity to chemotherapy observed in these patients.